Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
microbiome
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
clinical trials
pfizer
purdue pharma
abbvie
astrazeneca
biogen
bristol-myers squibb
cancer
diagnostics
eli lilly
What
bio
roundup
drug
moves
week
acquisitions
advantages
america
august
bar
biggest
biogen
biotech
brings
build
busy
buy
ceo
company’s
continues
convoluted
daniel
days
debut
decisions
democrats
devices
dreams
drugs
dyne’s
expect
fda
gamble
gilead
head
headaches
healthcare
holding
insurance
ipo
Language
unset
Current search:
microbiome
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More